Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Other Non-Current Assets (2017 - 2019)

Sunshine Biopharma (SBFM) has disclosed Other Non-Current Assets for 3 consecutive years, with $989572.0 as the latest value for Q2 2019.

  • For the quarter ending Q2 2019, Other Non-Current Assets changed N/A year-over-year to $989572.0, compared with a TTM value of $989572.0 through Jun 2019, changed N/A, and an annual FY2018 reading of $989572.0, up 1132.5% over the prior year.
  • Other Non-Current Assets was $989572.0 for Q2 2019 at Sunshine Biopharma, roughly flat from $989572.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $989572.0 in Q4 2018 and bottomed at $7756.0 in Q1 2018.
  • Average Other Non-Current Assets over 3 years is $611352.4, with a median of $989572.0 recorded in 2018.
  • The sharpest move saw Other Non-Current Assets skyrocketed 1132.5% in 2018, then skyrocketed 12658.79% in 2019.
  • Year by year, Other Non-Current Assets stood at $80290.0 in 2017, then surged by 1132.5% to $989572.0 in 2018, then changed by 0.0% to $989572.0 in 2019.
  • Business Quant data shows Other Non-Current Assets for SBFM at $989572.0 in Q2 2019, $989572.0 in Q1 2019, and $989572.0 in Q4 2018.